Integration of Aromatherapy and Essential Oils in Asthma Symptom Relief: A Narrative Review.
Health science reports · 2026
Abstract originale
BACKGROUND AND AIMS: Asthma affects 262 million people globally, causing 455,000 preventable deaths, with higher mortality in low-resource areas due to limited diagnosis and treatment. Aromatherapy, using bioactive essential oils (EOs), has emerged as a promising complementary approach for asthma symptom management. METHODS: This review synthesizes the current evidence on the therapeutic potential of EOs in alleviating asthma-related inflammation, bronchoconstriction, and immune dysregulation through anti-inflammatory, bronchodilatory, and immunomodulatory mechanisms. RESULTS: Key oils such as lavender, eucalyptus, and peppermint demonstrate efficacy in reducing airway hyperresponsiveness, oxidative stress, and Th2-mediated inflammation, supported by preclinical and clinical studies. Methods of application, including inhalation, topical use, and environmental diffusion, are evaluated for their physiological and psychological benefits, particularly in stress and sleep modulation, which are critical to asthma control. Safety considerations, such as allergenicity, proper dosing, and potential drug interactions, are emphasized to ensure safe integration with conventional therapies. CONCLUSION: Despite the promising findings, further large-scale clinical trials are needed to validate the efficacy, optimize protocols, and explore personalized approaches based on genetic and phenotypic variability. This review underscores aromatherapy's role as an adjunctive therapy within a holistic asthma management framework, bridging traditional knowledge with contemporary scientific validation to improve patient outcomes.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Integration of Aromatherapy and Essential Oils in Asthma Symptom Relief: A Narrative Review
ABSTRACT
Background and Aims
Asthma affects 262 million people globally, causing 455,000 preventable deaths, with higher mortality in low‐resource areas due to limited diagnosis and treatment. Aromatherapy, using bioactive essential oils (EOs), has emerged as a promising complementary approach for asthma symptom management.
Methods
This review synthesizes the current evidence on the therapeutic potential of EOs in alleviating asthma‐related inflammation, bronchoconstriction, and immune dysregulation through anti‐inflammatory, bronchodilatory, and immunomodulatory mechanisms.
Results
Key oils such as lavender, eucalyptus, and peppermint demonstrate efficacy in reducing airway hyperresponsiveness, oxidative stress, and Th2‐mediated inflammation, supported by preclinical and clinical studies. Methods of application, including inhalation, topical use, and environmental diffusion, are evaluated for their physiological and psychological benefits, particularly in stress and sleep modulation, which are critical to asthma control. Safety considerations, such as allergenicity, proper dosing, and potential drug interactions, are emphasized to ensure safe integration with conventional therapies.
Conclusion
Despite the promising findings, further large‐scale clinical trials are needed to validate the efficacy, optimize protocols, and explore personalized approaches based on genetic and phenotypic variability. This review underscores aromatherapy's role as an adjunctive therapy within a holistic asthma management framework, bridging traditional knowledge with contemporary scientific validation to improve patient outcomes.
Abbreviations
AEOAsarum sieboldii Radix essential oil
BALFbronchoalveolar lavage fluid
BC‐oilBupleurum chinense essential oil
BEObergamot essential oil
BSMCbronchial smooth muscle cells
CAMcomplementary and alternative medicine
CaMKIIcalcium/calmodulin‐dependent protein kinase II
CLEOChamaecyparis obtusa leaf essential oil
EOAAbies holophylla leaf essential oil
EOCZCroton zehntneri essential oil
EOPIPistacia integerrima essential oil
EOsessential oils
EPCAMepithelial cell adhesion molecule
FeNOfractional exhaled nitric oxide
FEV1forced expiratory volume in 1 s
FVCforced vital capacity
HCHouttuynia cordata essential oil
hs‐CRPhigh‐sensitivity C‐reactive protein
IFN‐γinterferon‐gamma
ILinterleukin
IP3Rinositol 1,4,5‐trisphosphate receptor
JAKjanus kinase
LPSlipopolysaccharide
MAPKmitogen‐activated protein kinase
MEFmaximum expiratory flow
MEOMentha essential oil
MMEFmaximum mid‐expiratory flow
NF‐κBnuclear factor kappa‐B
NLRP3NOD‐like receptor family pyrin domain containing 3
OVAovalbumin
PEFpeak expiratory flow
PFTpulmonary function test
PMparticulate matter
PM10particulate matter with a diameter of 10 micrometers or less
POSTNperiostin
RUNX3Runt‐related transcription factor 3
SERCA2Asarco/endoplasmic reticulum Ca2+‐ATPase 2A
SODsuperoxide dismutase
STATsignal transducer and activator of transcription
TGF‐βtransforming growth factor‐beta
ThT helper cells
TNF‐αtumor necrosis factor‐alpha
TPC2two‐pore channel 2
TRAF6TNF receptor associated factor 6
1Introduction
Aromatherapy is an integrative health modality that utilizes carefully administered plant‐derived essential oils to support both mental and physiological wellness [1]. This therapeutic intervention seeks to optimize holistic health outcomes by engaging multiple dimensions of wellness through the strategic use of botanical aromatic compounds. Essential oils (EOs) are the core components of aromatherapy, serving as the active agents responsible for its therapeutic effects. These oils are volatile compounds extracted from plants and are known for their distinct aromas and therapeutic properties [2]. The therapeutic properties of EOs stem from their intricate blend of volatile compounds, including terpenes, phenols, and esters. These compounds provide plants with adaptive advantages in their environment, such as attracting pollinators, repelling pests, and protecting against microbial infections [3]. When extracted and applied in aromatherapy, these same compounds can serve as important active principles in products intended for human treatment, offering a natural and holistic approach to healthcare [4].
Among the chronic diseases that may benefit from integrative strategies is asthma. While conventional pharmacotherapy, such as inhaled corticosteroids and bronchodilators, has significantly improved symptom control, many patients continue to experience suboptimal management due to medication side effects, limited access to care, or inadequate control of noninflammatory triggers like stress and poor sleep [5, 6, 7]. These challenges have prompted both patients and clinicians to explore complementary and alternative medicine (CAM). In this context, aromatherapy has gained increasing attention as a potential adjunctive therapy. Emerging evidence suggests that certain EOs possess anti‐inflammatory, bronchodilatory, mucolytic, antioxidant, and immunomodulatory properties that may directly address key pathophysiological features of asthma [8, 9]. Moreover, inhaled EOs act via the olfactory‐limbic pathway to exert central nervous system effects, offering a unique mechanism for mitigating stress‐ and anxiety‐induced bronchoconstriction [10, 11], a common yet often overlooked contributor to asthma exacerbations. This dual action positions aromatherapy as a compelling candidate for managing asthmatic conditions in which both physical airway constriction and psychological stress play significant roles.
Despite growing interest, the scientific validation of aromatherapy in asthma remains fragmented, with most data derived from preclinical models or small‐scale human trials. Therefore, this review aims to comprehensively synthesize current evidence on the efficacy, mechanisms of action, methods of application, and safety considerations of EOs in asthma management. It further explores the potential for personalized, integrative approaches that bridge traditional knowledge with modern biomedical science to enhance patient‐centered outcomes in a condition that continues to pose significant global health challenges.
1.1Asthma in the Modern World
Asthma is a chronic airway disease characterized by significant exacerbation of bronchial spasm (bronchospasm) and airway inflammation. This condition leads to the narrowing of the airways, making it difficult to breathe. Asthma is characterized by recurrent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly at night or early in the morning [12]. Exposure to fine particulate matter (PM) can intensify asthma symptoms, leading to increased airway inflammation and respiratory distress. PM, especially PM10 (particulate matter with a diameter of 10 micrometers or less), can penetrate deep into the lungs, causing airway epithelial remodeling, fibrosis, and pulmonary destruction in asthma [13]. This makes individuals with asthma particularly vulnerable to air pollution and environmental irritants. For instance, allergens such as pollen, dust mites, mold, and pet dander can provoke an immune response in the airways, leading to inflammation and bronchoconstriction. Environmental factors like air pollution, tobacco smoke, and cold air can also irritate the airways and trigger asthma symptoms [14]. Identifying and avoiding these triggers is a crucial aspect of asthma management, helping to reduce the frequency and severity of asthma attacks. Asthma represents a major global health challenge with significant implications for healthcare infrastructure and resource allocation. This chronic respiratory condition affects approximately 262 million individuals worldwide and was associated with 455,000 preventable deaths in 2019, with disproportionate mortality occurring in low‐resource settings where diagnostic and treatment gaps persist [12]. The clinical and economic burden of asthma is particularly evident in pediatric populations, where recurrent wheezing episodes demand substantial medical intervention and generate considerable healthcare expenditures. For instance, recent economic analyses reveal substantial healthcare expenditures associated with childhood asthma in the US healthcare system. Inflation‐adjusted data (2018 values) show that total direct costs reached $6.31 billion annually, with per‐patient expenditures varying between $3076 and $13,612 depending on disease severity [15]. These figures demonstrate significantly greater financial burdens for families with asthmatic children compared to those without respiratory conditions. The comprehensive costs of asthma management encompass direct medical expenses (including hospitalizations and pharmacotherapy) and indirect costs related to lost productivity [16]. Implementation of evidence‐based control strategies remains crucial for mitigating the societal and individual consequences of this prevalent condition.
2Bioactive Phytochemicals and Their Therapeutic Effects
The therapeutic potential of essential oils stems from their diverse phytochemical composition, as illustrated in Figure 1. Table 1 summarizes the essential oils used in asthma management, including their key bioactive phytochemicals and multifaceted therapeutic mechanisms.
2.1Anti‐Inflammatory Pathways
Essential oils demonstrate significant potential in managing asthma symptoms through multiple anti‐inflammatory pathways (Figure 2). These natural compounds modulate cytokine production and inhibit key inflammatory cascades involved in asthma pathogenesis, thereby reducing airway inflammation. Research indicates that essential oils from plants like Canarium indicum L., containing bioactive components such as linalool, p‐cymene, and γ‐terpinene, effectively lower malondialdehyde (MDA) levels, a marker of oxidative stress frequently elevated in asthmatic patients [35]. By decreasing lipid peroxidation, these oils mitigate tissue damage and inflammation associated with asthma. Furthermore, essential oils like Chamaecyparis obtusa leaf essential oil (CLEO) specifically target Th2‐mediated immune responses, significantly reducing the levels of pro‐inflammatory cytokines (IL‐4, IL‐5, and IL‐13) and IgE while decreasing eosinophil infiltration in the airways [36]. This multitargeted approach not only alleviates bronchial hyperresponsiveness but also addresses the underlying immunological dysregulation characteristic of allergic asthma, highlighting their potential as complementary anti‐inflammatory agents.
2.2Bronchodilation and Airway Clearance Mechanisms of Essential Oils
Essential oils demonstrate significant therapeutic potential in improving respiratory function through multiple mechanisms (Figure 2). Inhalation of eucalyptus‐based essential oils has been shown to effectively clear airway congestion and alleviate symptoms associated with respiratory conditions, including asthma, coughs, and sinusitis [17]. These benefits are frequently harnessed through inhalation therapies and topical applications like chest rubs, which help reduce bronchial constriction and facilitate easier breathing. The lipophilic properties of essential oils enable them to interact with cellular membranes, potentially disrupting viral particles that can trigger asthma exacerbations. This membrane interaction, combined with the synergistic action of multiple bioactive compounds, contributes to both antiviral effects and respiratory benefits, including bronchodilation and reduced mucus viscosity [37]. Among the key active components, 1,8‐cineole, found in various medicinal plants, including Eucalyptus species, Melaleuca cajuput, and Cinnamomum zeylanicum, plays a particularly important role in relaxing the airway smooth muscle tissue [18]. This monoterpene, along with other phytochemicals such as α‐pinene, limonene, and linalool, reduces bronchospasm and improves overall pulmonary function [38, 39], offering a multifaceted approach to managing asthma symptoms and maintaining airway patency.
2.3Immunomodulatory Effects of Essential Oils
Essential oils exhibit significant immunomodulatory properties that can help regulate the allergic responses and inflammation associated with asthma (Figure 2). Research indicates that these botanical extracts effectively lower pro‐inflammatory markers while enhancing anti‐inflammatory mediators, offering a promising complementary approach for managing immune‐related respiratory conditions [9]. Specific essential oils like Mentha piperita (peppermint) modulate key inflammatory pathways involved in pollution‐induced asthma. Studies reveal that peppermint oil targets the IL‐6/JAK2/STAT3 signaling cascade, significantly reducing the levels of pro‐inflammatory cytokines, particularly those produced by Th2 cells. This mechanism involves decreased phosphorylation of JAK2 and STAT3 proteins, leading to attenuated inflammatory responses in the PM10‐exposed airways [23]. Such targeted immunomodulation helps mitigate asthma symptoms aggravated by environmental pollutants, demonstrating the potential of essential oils to address both systemic and environmental triggers of respiratory inflammation.
2.4Therapeutic Synergy in Essential Oil Combinations
The multicomponent nature of essential oils creates synergistic interactions that enhance their medicinal properties beyond what single compounds can achieve. The complex interplay between these bioactive molecules is summarized in Table 2.
3Scientific Studies and Clinical Trials: Evaluating the Efficacy of Aromatherapy for Asthma
Aromatherapy has emerged as a promising complementary approach for asthma symptom management, providing a natural adjunct to conventional medical therapies without replacing them. This integrative treatment modality leverages the therapeutic properties of specific essential oils to address characteristic asthma symptoms, including wheezing, dyspnea, and persistent coughing.
3.1Human Clinical Trials
Recent clinical trials have demonstrated the therapeutic potential of plant‐derived compounds for treating asthma (Table 3). Carvacrol, a monoterpene, was evaluated in a randomized controlled trial involving patients with asthma [24]. After 2 months of treatment, the carvacrol group showed significant improvements in pulmonary function (FVC, MMEF, MEF), reduced respiratory symptoms (daytime wheezing, exercise‐induced symptoms), and decreased inflammatory markers (hs‐CRP, eosinophil counts). These findings suggest that carvacrol's anti‐inflammatory properties may underlie its clinical benefits. A subsequent study reinforced these results, showing that carvacrol additionally improved oxidative stress markers (reduced MDA, increased SOD) and rebalanced Th1/Th2 cytokines (elevated IFN‐γ, decreased IL‐4), further supporting its multimodal mechanism of action [43].
Zataria multiflora (containing thymol/carvacrol) was evaluated in a similar trial design [25]. The treatment group exhibited enhanced lung function (FEV1, MEF parameters), reduced nocturnal symptoms, and improved oxidative/immune profiles, including elevated antioxidant enzymes (catalase, SOD) and a shifted IFN‐γ/IL‐4 ratio via PBMC gene modulation. These studies collectively highlight how phytochemicals can simultaneously target inflammation, oxidative stress, and immune dysregulation in asthma. In contrast, the safety of an essential oil‐based air spray was assessed in patients with allergic asthma [44]. No significant changes occurred in FeNO, lung function, or symptom scores after the 4‐week exposure, suggesting tolerability in controlled asthma. However, increased odor perception was noted, emphasizing the need for individualized approaches in essential oil therapies.
3.2Animal Studies and Preclinical Research
3.2.1Modulation of the Inflammatory Pathways
Multiple studies have demonstrated that essential oils can effectively mitigate asthma‐related inflammation through various molecular mechanisms (Table 4). In a murine asthma model, lavender oil (Lvn) inhalation demonstrated significant anti‐inflammatory effects, including reduced airway hyperresponsiveness and decreased inflammatory cell infiltration in lung tissues and BAL fluid. The treatment notably suppressed Th2 cytokine production (IL‐5, IL‐13) and Muc5b expression, suggesting its potential for managing allergic airway inflammation [21]. Moreover, the effects of Abies holophylla leaf essential oil (EOA) on airway inflammation were examined using an asthma model [45]. Network pharmacology analysis linked EOA to the IL‐17 signaling pathway, a key player in asthma pathogenesis. In vivo experiments demonstrated that EOA inhalation reduced respiratory epithelial hyperplasia, collagen deposition, and goblet cell activation while decreasing inflammatory cells (eosinophils, lymphocytes, macrophages) in the bronchoalveolar lavage fluid (BALF). Additionally, EOA suppressed Th2 cytokines (IL‐4, IL‐5, and IL‐13) and IgE production by inhibiting IL‐17‐related pathways, including TRAF6‐NF‐κB and MAPK cascades, and modulating the Th17/Treg balance.
Mentha essential oil (MEO) was investigated in a particulate matter (PM10)‐induced asthma model, combining network pharmacology with in vitro and in vivo analyses [23]. Computational predictions identified cytokine–cytokine receptor interactions and JAK–STAT signaling as the key pathways targeted by MEO. In asthmatic mice, MEO inhalation attenuated PM10‐induced airway remodeling, collagen accumulation, and goblet cell hyperplasia. Cellular studies revealed that MEO downregulated pro‐inflammatory (IL‐6, TNF‐α, IL‐1β) and Th2‐associated cytokines (IL‐4, IL‐13) in PM10‐exposed A549 lung cells. Mechanistically, MEO inhibited JAK2/STAT3 activation and suppressed NF‐κB signaling by reducing IκB‐α phosphorylation and nuclear translocation of NF‐κB. These findings suggest that MEO alleviates PM10‐aggravated asthma by modulating the IL‐6/JAK2/STAT3 axis, offering a rationale for its use in the treatment of pollution‐related respiratory inflammation.
3.2.2Immunomodulatory and Antioxidant Effects
Essential oils demonstrate significant immunomodulatory potential in asthma management. Recently, safranal from saffron has been identified as an effective compound against asthma pathogenesis [46]. Research revealed that safranal restores RUNX3 expression in TNF‐α–stimulated airway smooth muscle cells, thereby mitigating inflammation and oxidative stress. In vivo studies showed safranal's ability to alleviate asthma symptoms through NLRP3/Caspase‐1 pathway modulation, with diminished effects in RUNX3‐deficient mice, highlighting its mechanism of action [46].
Similarly, bergamot essential oil (BEO), with d‐limonene and γ‐terpinene as major components, was investigated [27]. Network analysis suggested that BEO's anti‐asthma effects involve the MAPK and JAK–STAT pathways. In an OVA‐induced asthma model, BEO inhalation alleviated lung inflammation and airway remodeling while reducing Th2 cytokine and IgE levels. In vitro studies confirmed BEO's suppression of inflammatory mediators (IL‐6, IL‐1β, TNF‐α) in macrophages via MAPK and JAK–STAT inhibition, supporting its potential as a natural asthma treatment. Moreover, Asarum sieboldii Radix essential oil (AEO) was studied, and its primary compound, methyl eugenol, was found to share 48% of the asthma‐related gene targets [47]. In OVA/PM10‐induced asthma, AEO reduced airway remodeling, inflammatory cell infiltration, and IgE/IgG2a levels while downregulating pro‐inflammatory and Th2 cytokines. AEO also inhibited fibrotic mediators (POSTN, TGF‐β) and epithelial–mesenchymal transition markers, suggesting that its antifibrotic effects occur via POSTN/TGF‐β pathway modulation. These findings highlight AEO's potential in mitigating asthma‐related inflammation and fibrosis.
3.2.3Mucoregulatory
Essential oils demonstrate significant potential in addressing two critical aspects of asthma pathophysiology: mucus hypersecretion and secondary infections. A comparative analysis of essential oils from seven Lauraceae species revealed distinct phytochemical profiles. Cinnamomum camphora oil was rich in camphor (89.09%), while Lindera obtusiloba oil contained d‐limonene (10.27%) and β‐eudesmol (10.03%) [49]. Noncytotoxic concentrations of these oils suppressed IL‐1β and IL‐6 in LPS‐stimulated NCI‐H292 bronchial cells, with L. obtusiloba oil showing the highest efficacy. Notably, L. obtusiloba oil revealed potent mucoregulatory effects through the suppression of MUC5AC and MUC5B gene expression in bronchial epithelial cells. Other oils, such as those from C. cassia (linalool) and C. japonicum (1,8‐cineole), exhibited moderate anti‐inflammatory activity. This study underscores the potential of Lauraceae essential oils, particularly L. obtusiloba, as natural therapeutics for asthma‐associated mucus hypersecretion and inflammation.
3.2.4Bronchodilation and Airway Remodeling
Several essential oils have shown promise in improving respiratory function and preventing airway remodeling. Eucalyptus grandis essential oil and its primary component, 1,8‐cineole, were investigated, revealing significant anti‐asthmatic and antitussive properties in rodent models [19]. Both substances exhibited dose‐dependent effects in delaying asthma‐associated symptoms (wheezing, coughing) and demonstrated anti‐inflammatory activity in the cotton pellet granuloma assay. Notably, they induced vasorelaxation in rat aortic smooth muscle, suggesting potential bronchodilatory effects through direct smooth muscle relaxation, supporting their traditional use in respiratory therapeutics. Similarly, Pistacia integerrima essential oil (EOPI) was examined, demonstrating its multitarget antiasthmatic effects [48]. In vitro assays revealed EOPI's 5‐lipoxygenase inhibitory activity, antioxidant capacity (DPPH scavenging), and mast cell‐stabilizing properties. Ex vivo experiments on the guinea pig ileum showed EOPI‐mediated relaxation via L‐type calcium channel blockade, as evidenced by its inhibition of acetylcholine‐, histamine‐, and Bay K 8644‐induced contractions. EOPI also exhibited anti‐angiogenic effects in a chick chorioallantoic membrane model, suggesting its potential to mitigate airway remodeling. In vivo, EOPI reduced LPS‐induced pulmonary inflammation in rats by lowering inflammatory cell influx, myeloperoxidase activity, and oxidative stress markers in the bronchoalveolar fluid. In addition, it prevented ovalbumin (OVA)‐induced bronchoconstriction in sensitized guinea pigs, highlighting its dual anti‐inflammatory and bronchodilatory effects. These results align with the traditional applications of P. integerrima in respiratory disorders, underpinned by its 5‐lipoxygenase inhibition, calcium channel modulation, and antioxidant actions.
Moreover, Croton zehntneri essential oil (EOCZ) was evaluated in OVA‐induced asthma, demonstrating beneficial effects on lung mechanics and oxidative stress [51]. OVA‐challenged mice exhibited impaired respiratory function (elevated airway resistance, tissue elastance) and structural changes (alveolar collapse, inflammation), which were reversed by high‐dose EOCZ (300 mg/kg). EOCZ also normalized oxidative stress markers (catalase and superoxide dismutase), suggesting its dual anti‐inflammatory and antioxidant mechanisms. These findings support EOCZ as a complementary option for asthma management. Furthermore, Houttuynia cordata (HC) essential oil was investigated for its effects on calcium‐mediated airway remodeling [50]. In interleukin‐4/13–stimulated human bronchial smooth muscle cells (hBSMCs), increased expression of calcium channels (IP3R1, TPC2, and SERCA2A) and enhanced IP3‐mediated calcium release were observed, suggesting their involvement in asthma pathogenesis. HC essential oil pretreatment dose‐dependently reduced ATP‐induced calcium release in hBSMCs. In a house dust mite‐induced murine asthma model, nebulized HC essential oil attenuated airway inflammation (reduced neutrophils/eosinophils) and remodeling markers (airway thickness, smooth muscle hyperplasia), indicating its potential as an adjunct therapy for asthma. Zanthoxylum armatum essential oil, rich in linalool, has antiasthmatic properties [53]. In guinea pig and murine models, it prolonged histamine‐induced bronchoconstriction latency and reduced asthma biomarkers (IgE, eosinophils).
3.2.5Novel Mechanisms
Emerging research has revealed innovative mechanisms of action. For instance, Bupleurum chinense essential oil (BC‐oil) was explored in an OVA‐induced asthma model, and oral administration was shown to improve lung function and reduce inflammatory markers (IL‐2, eosinophils) [52]. Transcriptomic analysis implicated the olfactory receptor OR2W3 and CaMKII signaling in the BC‐oil mechanism. GC–MS identified linoleic acid as a key component capable of activating OR2W3, highlighting a novel pathway for essential oil‐mediated asthma relief. These findings bridge traditional use with modern pharmacology, suggesting that BC‐oil modulates ectopic olfactory receptors to exert anti‐inflammatory and antiproliferative effects in airway cells.
4Methods of Application
4.1Inhalation Methods
Aromatherapy inhalation harnesses the olfactory‐limbic connection to influence physiological and psychological states, with volatile compounds modulating breathing patterns via nasal chemoreceptors [4, 11, 54]. Clinical evidence supports these dual benefits; patients, including those with COVID‐19, reported improved respiratory function alongside reduced dyspnea and anxiety [55]. A randomized trial further validated this, showing that damask rose oil significantly lowered anxiety and improved sleep compared to placebo, supporting its role in integrative care [56]. Additionally, nebulization offers targeted delivery to deep lung tissue. Research on M. piperita demonstrated that inhalable aerosols reduced asthma pathologies, including collagen deposition and goblet cell metaplasia, by modulating the JAK/STAT inflammatory pathway [23].
4.2Topical Applications
Essential oils penetrate the skin to exert systemic healing effects, a process often complemented by the stimulation of olfactory receptors through inhalation. To ensure safety and improve absorption, these oils are typically diluted with carrier oils, which minimize the risk of skin irritation [57, 58]. Using diluents like fractionated coconut oil helps distribute the oils evenly and reduces the likelihood of adverse reactions [30]. Beyond systemic absorption, topical application provides targeted relief for muscle discomfort and promotes wound healing due to its antimicrobial and anti‐inflammatory properties [17, 59]. Furthermore, chest rubs can clear airways and alleviate congestion in respiratory conditions like asthma, making this dual topical and aromatic approach a valuable strategy for integrative wellness.
4.3Environmental Diffusion and Air Purification
While essential oil air sprays are popular, their safety for asthmatics requires caution due to limited research on potential bronchial irritation [44]. Conversely, diffusers provide effective, controlled exposure that facilitates stress modulation via the olfactory system [60]. This method offers dual benefits; botanicals like lavender and bergamot exhibit anxiolytic properties that mitigate stress, potentially improving respiratory outcomes given the link between emotional distress and asthma exacerbations [28].
5Safety Considerations and Potential Risks
5.1Allergic Reactions and Sensitization Risks
While essential oils are generally regarded as safe at appropriate dilutions, clinical evidence confirms their notable allergenic potential, necessitating careful usage protocols [4]. Essential oils carry a significant risk of allergic reactions, particularly in individuals with sensitive skin or pre‐existing allergies. The complex chemical composition of these plant‐derived extracts includes numerous bioactive compounds that may trigger contact dermatitis, respiratory irritation, or other hypersensitivity responses [61], underscoring the importance of preliminary patch testing before broader application. This precautionary approach helps identify potential allergens while minimizing the risk of severe dermatological or respiratory reactions, particularly in vulnerable populations.
5.2Importance of Proper Dosage and Concentration in Essential Oil Use
Regulating essential oil concentration is vital to minimize adverse effects, particularly for individuals with asthma, as improper use can intensify respiratory symptoms. High concentrations or undiluted application can trigger reactions ranging from skin irritation to respiratory discomfort [62]. Therefore, application requires well‐ventilated spaces and adherence to strict safety guidelines. For topical use, dilution with carrier oils is essential to reduce skin sensitivity; these diluents lower potency while facilitating gradual absorption [30]. Proper dilution ratios must always be tailored to individual needs to ensure safe therapeutic outcomes.
5.3Potential Drug Interactions With Essential Oils in Asthma Treatment
Essential oils may interact with asthma medications, potentially altering their efficacy or side effects. Consequently, patients should consult healthcare providers to ensure safe integration and avoid unintended consequences [58]. While aromatherapy offers complementary well‐being benefits, the current understanding of drug interactions is limited. Further research is therefore required to clarify pharmacological effects and establish evidence‐based guidelines for using essential oils concurrently with conventional treatments.
6The Psychological Impact of Aromatherapy on Asthma Management
Aromatherapy is increasingly recognized not only for its physiological effects but also for its psychological benefits in chronic respiratory conditions like asthma. As summarized in Table 5, essential oils have demonstrated clinically relevant effects in reducing anxiety, improving sleep quality, and enhancing patients' coping strategies.
7Future Directions and Research Needs
7.1Integrative and Personalized Approaches
Aromatherapy functions best as a supportive complement to standard asthma treatments rather than a replacement. Effective management integrates medication, lifestyle modifications, and complementary therapies to address both physiological and psychological aspects of the condition [65]. This holistic strategy relies on patient education and close collaboration with healthcare providers to develop personalized plans and monitor progress [66]. Future research should prioritize customizing regimens based on genetic biomarkers to improve therapeutic precision. Clinical applications must leverage aromatherapy's stress‐modulating capabilities [67], while ensuring treatments are individualized according to genetic and environmental factors to achieve optimal results [68].
7.2Large‐Scale Clinical Trials
To establish aromatherapy as a credible asthma therapy, rigorous large‐scale trials are required to assess its efficacy, safety, and long‐term impacts. Research must identify optimal application methods and essential oil combinations tailored to different patient phenotypes [69, 70]. While preliminary studies suggest benefits for symptom relief, sleep, and emotional well‐being, comprehensive evidence is necessary to validate these findings and establish standardized treatment protocols.
7.3Investigating Specific Mechanisms of Action
Comprehensive research is required to delineate the specific biological pathways and cellular targets of essential oils to optimize therapeutic applications [71]. Emerging evidence highlights immunomodulatory properties relevant to respiratory conditions [72], with Curcuma species demonstrating significant anti‐inflammatory potential [73]. Furthermore, advanced computational methods are currently being employed to analyze bioactive interactions with inflammatory pathways, potentially establishing a foundation for novel complementary treatments [74].
8Concluding Remarks
Aromatherapy and essential oils present a valuable complementary approach for asthma management, demonstrating potential benefits in symptom relief, inflammation reduction, and overall wellness enhancement. While existing studies offer encouraging evidence, additional rigorous research is necessary to establish standardized protocols regarding the effectiveness, safety profiles, and ideal administration methods. When incorporated as part of a comprehensive treatment strategy under medical supervision, aromatherapy may contribute to improved disease control and quality of life for patients with asthma.
Author Contributions
Alex Odoom: conceptualization, methodology, investigation, funding acquisition, writing – original draft, validation, visualization, writing – review and editing, software, formal analysis, project administration, data curation, supervision, resources. The author has read and approved the final version of the manuscript.
Funding
The author has nothing to report.
Disclosure
Alex Odoom affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.
Ethics Statement
The author has nothing to report.
Consent
The author has given consent for the publication of this manuscript.
Conflicts of Interest
The author declares no conflicts of interest.
References
1D. Reis and T. Jones , “Aromatherapy: Using Essential Oils as a Supportive Therapy ,” Clinical Journal of Oncology Nursing
21 , no. 1 (February 2017 ): 16 –19 .10.1188/17.CJON.16-19 28107335
2J. Liang , Y. Zhang , P. Chi , et al., “Essential Oils: Chemical Constituents, Potential Neuropharmacological Effects and Aromatherapy – A Review ,” Pharmacological Research – Modern Chinese Medicine
6 (March 2023 ): 100210.
3Y. Ben Miri , “Essential Oils: Chemical Composition and Diverse Biological Activities: A Comprehensive Review ,” Natural Product Communications
20 , no. 1 (January 2025 ): 1934578X241311790, 10.1177/1934578X241311790 .
4L. K. Vora , A. D. Gholap , N. T. Hatvate , et al., “Essential Oils for Clinical Aromatherapy: A Comprehensive Review ,” Journal of Ethnopharmacology
330 (August 2024 ): 118180.10.1016/j.jep.2024.118180 38614262
5M. E. Di Cicco , D. Peroni , G. L. Marseglia , and A. Licari , “Unveiling the Complexities of Pediatric Asthma Treatment: Evidence, Controversies, and Emerging Approaches ,” Pediatric Drugs
27 , no. 4 (July 2025 ): 393 –404 , https://pmc.ncbi.nlm.nih.gov/articles/PMC12187808/.10.1007/s40272-025-00694-6 PMC12187808 40120047
6F. Jaun , M. Boesing , G. Lüthi‐Corridori , et al., “Clinical Remission in Severe Asthma: A Comparative Analysis of Patients With and Without Biologics From the Swiss Severe Asthma Registry ,” Biomedicines
13 , no. 12 (December 2025 ): 3074 , https://www.mdpi.com/2227-9059/13/12/3074/htm.10.3390/biomedicines13123074 PMC12730426 41463083
7B. A. Dubaybo , “The Care of Asthma Patients in Communities With Limited Resources ,” Research and Reports in Tropical Medicine
12 (March 2021 ): 33 –38 , https://pmc.ncbi.nlm.nih.gov/articles/PMC7954422/.10.2147/RRTM.S247716 PMC7954422 33727880
8L. J. Juergens , H. Worth , and U. R. Juergens , “New Perspectives for Mucolytic, Anti‐Inflammatory and Adjunctive Therapy With 1,8‐Cineole in COPD and Asthma: Review on the New Therapeutic Approach ,” Advances in Therapy
37 , no. 5 (May 2020 ): 1737 –1753 , https://pmc.ncbi.nlm.nih.gov/articles/PMC7467491/.10.1007/s12325-020-01279-0 PMC7467491 32200535
9G. R. Gandhi , A. B. S. Vasconcelos , G. H. Haran , et al., “Essential Oils and Its Bioactive Compounds Modulating Cytokines: A Systematic Review on Anti‐Asthmatic and Immunomodulatory Properties ,” Phytomedicine
73 (July 2020 ): 152854, https://pubmed.ncbi.nlm.nih.gov/31036393/.10.1016/j.phymed.2019.152854 31036393
10J. Liu , M. Liu , L. Peng , H. He , R. Sun , and W. Chang , “Effects of Inhaling Cunninghamia lanceolata Essential Oil on the Physiological and Psychological Relaxation of University Students ,” Frontiers in Psychology
16 (September 2025 ): 1638492.10.3389/fpsyg.2025.1638492 PMC12504257 41069676
11J. Cui , M. Li , Y. Wei , et al., “Inhalation Aromatherapy via Brain‐Targeted Nasal Delivery: Natural Volatiles or Essential Oils on Mood Disorders ,” Frontiers in Pharmacology
13 (April 2022 ): 860043, https://pmc.ncbi.nlm.nih.gov/articles/PMC9041268/.10.3389/fphar.2022.860043 PMC9041268 35496310
12WHO, “Asthma,” WHO, cited April 11, 2025, https://www.who.int/news-room/fact-sheets/detail/asthma.
13J. T. Pryor , L. O. Cowley , and S. E. Simonds , “The Physiological Effects of Air Pollution: Particulate Matter, Physiology and Disease,” Frontiers in Public Health 10 (2022 ): 882569, www.frontiersin.org.10.3389/fpubh.2022.882569 PMC9329703 35910891
14R. Chabra and M. Gupta , Allergic and Environmentally Induced Asthma (StatPearls, 2023 ), https://www.ncbi.nlm.nih.gov/books/NBK526018/.
15R. Perry , G. Braileanu , T. Palmer , and P. Stevens , “The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence ,” PharmacoEconomics
37 , no. 2 (February 2019 ): 155 –167 , https://pubmed.ncbi.nlm.nih.gov/30315512/.10.1007/s40273-018-0726-2 PMC6386052 30315512
16H. J. Song , K. V. Blake , D. L. Wilson , A. G. Winterstein , and H. Park , “Medical Costs and Productivity Loss Due to Mild, Moderate, and Severe Asthma in the United States ,” Journal of Asthma and Allergy
13 (2020 ): 545 , https://pmc.ncbi.nlm.nih.gov/articles/PMC7605920/.10.2147/JAA.S272681 PMC7605920 33149626
17R. A. E. Shiekh , A. M. Atwa , A. M. Elgindy , et al., “Therapeutic Applications of Eucalyptus Essential Oils ,” Inflammopharmacology
33 , no. 1 (January 2025 ): 163 –182 , http://www.ncbi.nlm.nih.gov/pubmed/39499358.10.1007/s10787-024-01588-8 PMC11799053 39499358
18C. C. Hoch , J. Petry , L. Griesbaum , et al., “1,8‐Cineole (Eucalyptol): A Versatile Phytochemical With Therapeutic Applications Across Multiple Diseases ,” Biomedicine & Pharmacotherapy
167 (November 2023 ): 115467.10.1016/j.biopha.2023.115467 37696087
19O. S. Soyingbe , T. J. Makhafola , B. P. Mahlobo , H. M. Salahdeen , O. A. Lawal , and A. R. Opoku , “Antiasthma Activity of Eucalyptus grandis Essential Oil and Its Main Constituent: Vasorelaxant Effect on Aortic Smooth Muscle Isolated From Nomotensive Rats ,” Journal of Experimental and Applied Animal Sciences
2 , no. 2 (July 2017 ): 211 –222 .
20D. Donelli , M. Antonelli , C. Bellinazzi , G. F. Gensini , and F. Firenzuoli , “Effects of Lavender on Anxiety: A Systematic Review and Meta‐Analysis ,” Phytomedicine
65 (December 2019 ): 153099.10.1016/j.phymed.2019.153099 31655395
21T. Ueno‐Iio , M. Shibakura , K. Yokota , et al., “Lavender Essential Oil Inhalation Suppresses Allergic Airway Inflammation and Mucous Cell Hyperplasia in a Murine Model of Asthma ,” Life Sciences
108 , no. 2 (July 2014 ): 109 –115 .10.1016/j.lfs.2014.05.018 24909715
22O. Yoo and S. A. Park , “Anxiety‐Reducing Effects of Lavender Essential Oil Inhalation: A Systematic Review ,” Healthcare
11 , no. 22 (November 2023 ): 2978 , https://www.mdpi.com/2227-9032/11/22/2978/htm.10.3390/healthcare11222978 PMC10671255 37998470
23M. H. Kim , S. J. Park , and W. M. Yang , “Inhalation of Essential Oil From Mentha piperita Ameliorates PM10‐Exposed Asthma by Targeting IL‐6/JAK2/STAT3 Pathway Based on a Network Pharmacological Analysis ,” Pharmaceuticals
14 , no. 1 (January 2020 ): 2 , https://pmc.ncbi.nlm.nih.gov/articles/PMC7821947/.10.3390/ph14010002 PMC7821947 33374928
24A. Alavinezhad , M. R. Khazdair , and M. H. Boskabady , “Possible Therapeutic Effect of Carvacrol on Asthmatic Patients: A Randomized, Double Blind, Placebo‐Controlled, Phase II Clinical Trial ,” Phytotherapy Research
32 , no. 1 (January 2018 ): 151 –159 , https://onlinelibrary.wiley.com/doi/full/10.1002/ptr.5967.10.1002/ptr.5967 29193478
25A. Alavinezhad , V. Ghorani , O. Rajabi , and M. H. Boskabady , “Zataria multiflora Affects Clinical Symptoms, Oxidative Stress and Cytokines in Asthmatic Patient: A Randomized, Double Blind, Placebo‐Controlled, Phase II Clinical Trial ,” Cytokine
133 (September 2020 ): 155169.10.1016/j.cyto.2020.155169 32585581
26B. Salehi , S. Upadhyay , I. Erdogan Orhan , et al., “Therapeutic Potential of α‐ and β‐Pinene: A Miracle Gift of Nature ,” Biomolecules
9 , no. 11 (November 2019 ): 738 , https://pmc.ncbi.nlm.nih.gov/articles/PMC6920849/.10.3390/biom9110738 PMC6920849 31739596
27S. Feng , G. Xu , Y. Fu , Q. Ding , and Y. Shi , “Exploring the Mechanism of Bergamot Essential Oil Against Asthma Based on Network Pharmacology and Experimental Verification ,” ACS Omega
8 , no. 11 (March 2023 ): 10202 –10213 , https://pubs.acs.org/doi/full/10.1021/acsomega.2c07366.10.1021/acsomega.2c07366 PMC10034984 36969419
28T. K. H. Fung , B. W. M. Lau , S. P. C. Ngai , and H. W. H. Tsang , “Therapeutic Effect and Mechanisms of Essential Oils in Mood Disorders: Interaction Between the Nervous and Respiratory Systems ,” International Journal of Molecular Sciences
22 , no. 9 (May 2021 ): 4844 , https://pmc.ncbi.nlm.nih.gov/articles/PMC8125361/.10.3390/ijms22094844 PMC8125361 34063646
29A. Aswandi and C. R. Kholibrina , “Ethnomedicine of Forest's Essential Oils for Respiratory and Cardiovascular Treatments in Northern Sumatra ,” IOP Conference Series: Earth and Environmental Science
914 , no. 1 (November 2021 ): 012073.
30T. K. Lin , L. Zhong , and J. Santiago , “Anti‐Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils ,” International Journal of Molecular Sciences
19 , no. 1 (January 2017 ): 70 , https://pmc.ncbi.nlm.nih.gov/articles/PMC5796020/.10.3390/ijms19010070 PMC5796020 29280987
31D. F. Martins , A. A. Emer , A. P. Batisti , et al., “Inhalation of Cedrus atlantica Essential Oil Alleviates Pain Behavior Through Activation of Descending Pain Modulation Pathways in a Mouse Model of Postoperative Pain ,” Journal of Ethnopharmacology
175 (December 2015 ): 30 –38 .10.1016/j.jep.2015.08.048 26344850
32S. K. Kim , S. M. Lee , and H. B. Lim , “Attenuation Effect of Chamaecyparis obtusa Leaf Essential Oils on Airway Hyperresponsiveness and in Ovalbumin‐Induced Murine Asthma Model ,” Korean Journal of Medicinal Crop Science
23 , no. 3 (June 2015 ): 237 –244 .
33K. Bhardwaj , A. S. Silva , M. Atanassova , et al., “Conifers Phytochemicals: A Valuable Forest With Therapeutic Potential ,” Molecules
26 , no. 10 (May 2021 ): 3005 , https://www.mdpi.com/1420-3049/26/10/3005/htm.10.3390/molecules26103005 PMC8158490 34070179
34A. U. Khan , Q. J. Khan , and A. H. Gilani , “Pharmacological Basis for the Medicinal Use of Cardamom in Asthma ,” Bangladesh Journal of Pharmacology
6 , no. 1 (August 2011 ): 34 –37 , https://www.banglajol.info/index.php/BJP/article/view/8133/24739.
35F. Fachrudin Mbabho , A. Aulanni'am , and A. Srihardyastutie , “Influence of Treating Essential Oils of Canarium Tree Resin on the Level Malondialdehyde (MDA), Protease Activity, Bronchi Histopathology Description and Expression of Tumor Necrosis Alpha Factor (TNF‐α) on Asthma Rats (Rattus norvegicus) ,” Journal of Pure and Applied Chemistry Research
7 , no. 3 (September 2018 ): 282 –291 .
36S. H. Shin , M. K. Ye , D. W. Lee , and M. H. Che , “Immunomodulative Effects of Chamaecyparis obtusa Essential Oil in Mouse Model of Allergic Rhinitis ,” Molecules
25 , no. 19 (October 2020 ): 4517 , https://pmc.ncbi.nlm.nih.gov/articles/PMC7582496/.10.3390/molecules25194517 PMC7582496 33023110
37D. Mieres‐Castro , S. Ahmar , R. Shabbir , and F. Mora‐Poblete , “Antiviral Activities of Eucalyptus Essential Oils: Their Effectiveness as Therapeutic Targets Against Human Viruses ,” Pharmaceuticals
14 , no. 12 (December 2021 ): 1210 , https://pmc.ncbi.nlm.nih.gov/articles/PMC8706319/.10.3390/ph14121210 PMC8706319 34959612
38X. Y. Qiu , L. S. Yan , J. Y. Kang , et al., “Eucalyptol, Limonene and Pinene Enteric Capsules Attenuate Airway Inflammation and Obstruction in Lipopolysaccharide‐Induced Chronic Bronchitis Rat Model via TLR4 Signaling Inhibition ,” International Immunopharmacology
129 (March 2024 ): 111571, https://www.sciencedirect.com/science/article/pii/S1567576924000894.10.1016/j.intimp.2024.111571 38309095
39H. S. R. Santana , F. O. de Carvalho , D. Menezes dos Santos , et al., “Inhaled d‐Limonene Minimizes Acute Lung Injury and Reduces Oxidative Stress Induced by Smoke in Rats ,” Phytomedicine Plus
2 , no. 3 (August 2022 ): 100308.
40M. Bunse , R. Daniels , C. Gründemann , et al., “Essential Oils as Multicomponent Mixtures and Their Potential for Human Health and Well‐Being ,” Frontiers in Pharmacology
13 (August 2022 ): 956541, https://pmc.ncbi.nlm.nih.gov/articles/PMC9449585/.10.3389/fphar.2022.956541 PMC9449585 36091825
41G. I. Edo , P. O. Samuel , S. Ossai , et al., “Phytochemistry and Pharmacological Compounds Present in Scent Leaf: A Review ,” Food Chemistry Advances
3 (December 2023 ): 100300.
42F. Hedigan , H. Sheridan , and A. Sasse , “Benefit of Inhalation Aromatherapy as a Complementary Treatment for Stress and Anxiety in a Clinical Setting – A Systematic Review ,” Complementary Therapies in Clinical Practice
52 (August 2023 ): 101750.10.1016/j.ctcp.2023.101750 37031643
43V. Ghorani , A. Alavinezhad , O. Rajabi , and M. H. Boskabady , “Carvacrol Improves Pulmonary Function Tests, Oxidant/Antioxidant Parameters and Cytokine Levels in Asthmatic Patients: A Randomized, Double‐Blind, Clinical Trial ,” Phytomedicine
85 (May 2021 ): 153539.10.1016/j.phymed.2021.153539 33773189
44J. Levy , C. Neukirch , I. Larfi , P. Demoly , and G. Thabut , “Tolerance to Exposure to Essential Oils Exposure in Patients With Allergic Asthma ,” Journal of Asthma
56 , no. 8 (August 2019 ): 853 –860 , https://pubmed.ncbi.nlm.nih.gov/29985684/.10.1080/02770903.2018.1493601 29985684
45N. Park , S. J. Park , M. H. Kim , and W. M. Yang , “Efficacy and Mechanism of Essential Oil From Abies holophylla Leaf on Airway Inflammation in Asthma: Network Pharmacology and In Vivo Study ,” Phytomedicine
96 (February 2022 ): 153898.10.1016/j.phymed.2021.153898 35026513
46X. Zhang , X. Li , P. Wang , S. Zhao , and Y. Zhao , “Safranal Restores RUNX3‐Mediated Immunoregulation by Inhibiting the NLRP3 Inflammasome in Allergic Asthma ,” Naunyn‐Schmiedeberg's Archives of Pharmacology
398 (March 2025 ): 1 –17 , https://link.springer.com/article/10.1007/s00210-025-03943-0.10.1007/s00210-025-03943-0 40163148
47J. M. Han , M. H. Kim , L. Y. Choi , G. Kim , and W. M. Yang , “Exploring the Potential Effects and Mechanisms of Asarum sieboldii Radix Essential Oil for Treatment of Asthma ,” Pharmaceutics
14 , no. 3 (March 2022 ): 558 , https://www.mdpi.com/1999-4923/14/3/558/htm.10.3390/pharmaceutics14030558 PMC8953372 35335934
48R. L. Shirole , N. L. Shirole , A. A. Kshatriya , R. Kulkarni , and M. N. Saraf , “Investigation Into the Mechanism of Action of Essential Oil of Pistacia integerrima for Its Antiasthmatic Activity ,” Journal of Ethnopharmacology
153 , no. 3 (May 2014 ): 541 –551 , https://pubmed.ncbi.nlm.nih.gov/24556221/.10.1016/j.jep.2014.02.009 24556221
49J. Yang , S. Y. Lee , H. Na , S. K. Jang , and M. J. Park , “Evaluation of Anti‐Asthmatic Activity of Essential Oils From the Lauraceae Family in Lipopolysaccharide (LPS)‐Stimulated NCI‐H292 Cells ,” Journal of the Korean Wood Science and Technology
50 , no. 6 (2022 ): 414 –426 , http://www.woodj.org/archive/view_article?pid=wood-50-6-414.
50A. S. Huang , B. C. K. Tong , H. C. H. Hung , et al., “Targeting Calcium Signaling by Inositol Trisphosphate Receptors: A Novel Mechanism for the Anti‐Asthmatic Effects of Houttuynia cordata
,” Biomedicine & Pharmacotherapy 164 (August 2023 ): 114935, https://pubmed.ncbi.nlm.nih.gov/37245337/.10.1016/j.biopha.2023.114935 37245337
51D. S. Serra , M. D. M. Gomes , F. S. Á. Cavalcante , and J. H. Leal‐Cardoso , “Essential Oil of Croton zehntneri Attenuates Lung Injury in the OVA‐Induced Asthma Model ,” Journal of Asthma
56 , no. 1 (January 2019 ): 1 –10 , https://pubmed.ncbi.nlm.nih.gov/29437496/.10.1080/02770903.2018.1430828 29437496
52B. Li , L. Zheng , A. Yuan , et al., “Mechanism Analysis of Essential Oil From Radix Bupleuri for the Treatment of Asthma Through Regulation of Ectopic Olfactory Receptor,” Journal of Ethnopharmacology 334 (November 2024 ): 118592, https://pubmed.ncbi.nlm.nih.gov/39025162/.10.1016/j.jep.2024.118592 39025162
53S. Sharma , V. P. Rasal , R. K. Joshi , and P. A. Patil , “In Vivo Evaluation of Antiasthmatic Activity of the Essential Oil of Zanthoxylum armatum
,” Indian Journal of Pharmaceutical Sciences
80 , no. 2 (March 2018 ): 383 –390 .
54N. Y. Choi , Y. T. Wu , and S. A. Park , “Effects of Olfactory Stimulation With Aroma Oils on Psychophysiological Responses of Female Adults ,” International Journal of Environmental Research and Public Health
19 , no. 9 (May 2022 ): 5196 , https://pmc.ncbi.nlm.nih.gov/articles/PMC9102723/.10.3390/ijerph19095196 PMC9102723 35564590
55H. Y. Kang , H. Y. Ahn , M. J. Kang , and M. H. Hur , “Effects of Aromatherapy on Sore Throat, Nasal Symptoms and Sleep Quality in Adults Infected With COVID‐19: A Randomized Controlled Trial ,” Integrative Medicine Research
12 , no. 4 (December 2023 ): 101001.10.1016/j.imr.2023.101001 PMC10654541 38024288
56B. Mahdood , B. Imani , and S. Khazaei , “Effects of Inhalation Aromatherapy With Rosa damascena (Damask Rose) on the State Anxiety and Sleep Quality of Operating Room Personnel During the COVID‐19 Pandemic: A Randomized Controlled Trial ,” Journal of Perianesthesia Nursing
37 , no. 4 (August 2022 ): 493 –500 , https://www.jopan.org/action/showFullText?pii=S1089947221003543.10.1016/j.jopan.2021.09.011 PMC8554138 35256247
57N. Kashyap , A. Kumari , N. Raina , F. Zakir , and M. Gupta , “Prospects of Essential Oil Loaded Nanosystems for Skincare ,” Phytomedicine Plus
2 , no. 1 (February 2022 ): 100198.
58B. Ali , N. A. Al‐Wabel , S. Shams , A. Ahamad , S. A. Khan , and F. Anwar , “Essential Oils Used in Aromatherapy: A Systemic Review ,” Asian Pacific Journal of Tropical Biomedicine
5 , no. 8 (August 2015 ): 601 –611 .
59E. Bakó , P. Fehérvári , A. Garami , et al., “Efficacy of Topical Essential Oils in Musculoskeletal Disorders: Systematic Review and Meta‐Analysis of Randomized Controlled Trials ,” Pharmaceuticals
16 , no. 2 (February 2023 ): 144 , https://pmc.ncbi.nlm.nih.gov/articles/PMC9959659/.10.3390/ph16020144 PMC9959659 37259296
60B. Du , H. Schwartz‐Narbonne , M. Tandoc , E. M. Heffernan , M. L. Mack , and J. A. Siegel , “The Impact of Emissions From an Essential Oil Diffuser on Cognitive Performance ,” Indoor Air
32 , no. 1 (January 2022 ): e12919, https://onlinelibrary.wiley.com/doi/full/10.1111/ina.12919.10.1111/ina.12919 34709668
61A. Sindle and K. Martin , “Art of Prevention: Essential Oils ‐ Natural Products Not Necessarily Safe ,” International Journal of Women's Dermatology
7 , no. 3 (June 2022 ): 304 –308 , https://pmc.ncbi.nlm.nih.gov/articles/PMC8243157/.10.1016/j.ijwd.2020.10.013 PMC8243157 34222588
62S. E. Brennan , S. McDonald , M. Murano , and J. E. McKenzie , “Effectiveness of Aromatherapy for Prevention or Treatment of Disease, Medical or Preclinical Conditions, and Injury: Protocol for a Systematic Review and Meta‐Analysis ,” Systematic Reviews
11 , no. 1 (December 2022 ): 148 , https://pmc.ncbi.nlm.nih.gov/articles/PMC9317467/.10.1186/s13643-022-02015-1 PMC9317467 35883155
63E. Karadag , S. Samancioglu , D. Ozden , and E. Bakir , “Effects of Aromatherapy on Sleep Quality and Anxiety of Patients ,” Nursing in Critical Care
22 , no. 2 (March 2017 ): 105 –112 , https://pubmed.ncbi.nlm.nih.gov/26211735/.10.1111/nicc.12198 26211735
64Ç. Toprak , P. Ergin Ozcan , İ. Demirbolat , A. Kalaycioglu , and N. Akyuz , “The Effect of Lavender and Bergamot Oil Applied via Inhalation on the Anxiety Level and Sleep Quality of Surgical Intensive Care Unit Patients ,” Explore
20 , no. 5 (September 2024 ): 102991, https://pubmed.ncbi.nlm.nih.gov/38490827/.10.1016/j.explore.2024.02.009 38490827
65M. George and M. Topaz , “A Systematic Review of Complementary and Alternative Medicine for Asthma Self‐Management ,” Nursing Clinics of North America
48 , no. 1 (March 2013 ): 53 –149 , 10.1016/j.cnur.2012.11.002 .PMC3859131 23465447
66H. Pinnock , M. Noble , D. Lo , K. McClatchey , V. Marsh , and C. Y. Hui , “Personalised Management and Supporting Individuals to Live With Their Asthma in a Primary Care Setting ,” Expert Review of Respiratory Medicine
17 , no. 7 (July 2023 ): 577 –596 , https://www.tandfonline.com/doi/abs/10.1080/17476348.2023.2241357.10.1080/17476348.2023.2241357 37535011
67K. Caballero‐Gallardo , P. Quintero‐Rincón , and J. Olivero‐Verbel , “Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing ,” Plants
14 , no. 3 (January 2025 ): 400 , https://www.mdpi.com/2223-7747/14/3/400/htm.10.3390/plants14030400 PMC11821193 39942962
68T. Tsusaka , B. Makino , R. Ohsawa , and H. Ezura , “Genetic and Environmental Factors Influencing the Contents of Essential Oil Compounds in Atractylodes lancea
,” PLoS One
14 , no. 5 (May 2019 ): e0217522.10.1371/journal.pone.0217522 PMC6538177 31136627
69V. Gonzalez‐Uribe , S. J. Romero‐Tapia , and J. A. Castro‐Rodriguez , “Asthma Phenotypes in the Era of Personalized Medicine ,” Journal of Clinical Medicine
12 , no. 19 (September 2023 ): 6207 , https://www.mdpi.com/2077-0383/12/19/6207/htm.10.3390/jcm12196207 PMC10573947 37834850
70M. E. Kuruvilla , F. E. H. Lee , and G. B. Lee , “Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease ,” Clinical Reviews in Allergy & Immunology
56 , no. 2 (April 2019 ): 219 –233 , https://pmc.ncbi.nlm.nih.gov/articles/PMC6411459/.10.1007/s12016-018-8712-1 PMC6411459 30206782
71G. M. Mounira , “Essential Oils and Their Bioactive Molecules: Recent Advances and New Applications,” in Essential Oils—Recent Advances, New Perspectives and Applications (InTechOpen, 2024 ), https://www.intechopen.com/chapters/88578.
72G. Sandner , M. Heckmann , and J. Weghuber , “Immunomodulatory Activities of Selected Essential Oils ,” Biomolecules
10 , no. 8 (August 2020 ): 1139 , https://pmc.ncbi.nlm.nih.gov/articles/PMC7464830/.10.3390/biom10081139 PMC7464830 32756359
73N. S. Dosoky and W. N. Setzer , “Chemical Composition and Biological Activities of Essential Oils of Curcuma Species ,” Nutrients
10 , no. 9 (September 2018 ): 1196 , https://pmc.ncbi.nlm.nih.gov/articles/PMC6164907/.10.3390/nu10091196 PMC6164907 30200410
74A. Maruca , D. Lanzillotta , R. Rocca , et al., “Multi‐Targeting Bioactive Compounds Extracted From Essential Oils as Kinase Inhibitors ,” Molecules
25 , no. 9 (May 2020 ): 2174 , https://www.mdpi.com/1420-3049/25/9/2174/htm.10.3390/molecules25092174 PMC7249159 32384767
Come citare questo studio
Odoom A. (2026). Integration of Aromatherapy and Essential Oils in Asthma Symptom Relief: A Narrative Review.. Health science reports. DOI: 10.1002/hsr2.73425
Consulta la pubblicazione originale ↗